Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China-Reference-Cited by-同舟云学术

Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China

Published:2012-10-22 Issue:12 Volume:33 Page:1563-1570
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Meng Xiang-guang,Guo Cheng-xian,Feng Guo-qing,Zhao Ying-chun,Zhou Bo-ting,Han Jian-le,Chen Xin,Shi Yong,Shi Hong-yao,Yin Ji-ye,Peng Xiang-dong,Pei Qi,Zhang Wei,Wang Guo,He Meng,Liu Min,Yang Jing-ke,Zhou Hong-hao

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/aps2012136.pdf

Reference35 articles.

1. Colombo D, Ammirati E . Cyclosporine in transplantation – a history of converging timelines. J Biol Regul Homeost Agents 2011; 25: 493–504.

2. Masuda S, Inui K . An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients. Pharmacol Ther 2006; 112: 184–98.

3. Garcia-Saiz M, Lopez-Gil A, Alfonso I, Boada JN, Armijo JA . Factors influencing cyclosporine blood concentration-dose ratio. Ann Pharmacother 2002; 36: 193–9.

4. Roy JN, Lajoie J, Zijenah LS, Barama A, Poirier C, Ward BJ, et al. CYP3A5 genetic polymorphisms in different ethnic populations. Drug Metab Dispos 2005; 33: 884–7.

5. Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 2001; 27: 383–91.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between CYP3A5 Gene Polymorphism and Post-Transplant Acute Immune Rejection in Renal Transplant Recipients Receiving Tacrolimus Therapy: A Correlation Study;Archivos Españoles de Urología;2024

2. HDL-C and creatinine levels at 1 month are associated with patient 12-month survival rate after kidney transplantation;Pharmacogenetics and Genomics;2023-12-04

3. Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients;Biomedicines;2022-07-26

4. Population Pharmacokinetic Modelling for Nifedipine to Evaluate the Effect of Parathyroid Hormone on CYP3A in Patients with Chronic Kidney Disease;Drug Design, Development and Therapy;2022-07

5. Association Between CYP3A4 and CYP3A5 Genotypes and Cyclosporine's Blood Levels and Doses among Jordanian Kidney Transplanted Patients;Current Drug Metabolism;2019-09-24